High lead level in respiratory supplement
This article was originally published in The Tan Sheet
Executive Summary
FDA advises consumers not to use Vita Breath herbal supplements, manufactured by American Herbal Lab Inc. of Rosemead, Calif., because tests showed it contains lead at more than 10,000 times the maximum recommended level. New York City health officials notified FDA May 1 after a patient with lead poisoning reported taking Vita Breath and two other herbal products. The NYC officials analyzed a sample of Vita Breath and found it contained 1,100 parts per million of lead. FDA and New York and California officials are investigating Vita Breath, which American Herbal Lab says "supports healthy lung energy and respiratory system." The firm markets 46 products under the new vita brand. FDA's advisory comes after researchers asked the agency to tighten supplement regulation in part to block products with dangerous levels of lead from reaching the market (1"The Tan Sheet" Dec. 7, 2009)
You may also be interested in...
Herbal/Lead Study Calls For Pre-Market Approval, Draws Fire From Industry
A correlation between the use of some herbal supplements and increased blood lead levels in women should prompt tighter FDA regulation of supplements, including requiring pre-market approval, researchers say
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.